MATILDE
MERINO SANJUAN
CATEDRÁTICO/A DE UNIVERSIDAD
VICTOR
MANGAS SANJUAN
TITULAR DE UNIVERSIDAD
Publicaciones en las que colabora con VICTOR MANGAS SANJUAN (24)
2024
-
Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomers
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 199
-
Phys-DAT: A physiologically-based pharmacokinetic model for unraveling the dissolution, transit and absorption processes using PhysPK®
Computer Methods and Programs in Biomedicine, Vol. 243
2023
-
Application of population physiologically based pharmacokinetic modelling to optimize target expression and clearance mechanisms of therapeutic monoclonal antibodies
British Journal of Clinical Pharmacology, Vol. 89, Núm. 9, pp. 2691-2702
-
Commonly used methods for dissolution profile comparison
Time-Proof Perspectives on Bioequivalence (Nova Science Publishers, Inc.), pp. 297-322
-
Desarrollo y validación de un modelo farmacocinético fisiológico para las formas ácidas y lactonizadas de atorvastatina y sus dos metabolitos
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
2022
-
A physiologically based pharmacokinetic model for open acid and lactone forms of atorvastatin and metabolites to assess the drug-gene interaction with SLCO1B1 polymorphisms
Biomedicine and Pharmacotherapy, Vol. 156
-
Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis
Pharmaceutics, Vol. 14, Núm. 3
-
Pharmacometric characterization of entero-hepatic circulation processes of orally administered formulations of amiodarone under complex binding kinetics
European Journal of Pharmaceutical Sciences, Vol. 174
-
Population Pharmacokinetic/Pharmacodynamic Modelling of Daptomycin for Schedule Optimization in Patients with Renal Impairment
Pharmaceutics, Vol. 14, Núm. 10
-
Quantitative assessment of the exposure–efficacy relationship of glucocerebrosidase using Markovian elements in Gaucher patients treated with enzyme replacement therapy
British Journal of Clinical Pharmacology, Vol. 88, Núm. 6, pp. 2727-2737
2021
-
Current evidence, challenges, and opportunities of physiologically based pharmacokinetic models of atorvastatin for decision making
Pharmaceutics, Vol. 13, Núm. 5
-
Estimators and Confidence Intervals of f_2 Using Bootstrap Methodology for the Comparison of Dissolution Profiles
RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 54-56
-
Estimators and confidence intervals of f2 using bootstrap methodology for the comparison of dissolution profiles
Computer Methods and Programs in Biomedicine, Vol. 212
-
Evaluation of ABC gene polymorphisms on the pharmacokinetics and pharmacodynamics of capecitabine in colorectal patients: Implications for dosing recommendations
British Journal of Clinical Pharmacology, Vol. 87, Núm. 3, pp. 905-915
2020
-
A multilevel object-oriented modelling methodology for physiologically-based pharmacokinetics (PBPK): Evaluation with a semi-mechanistic pharmacokinetic model
Computer Methods and Programs in Biomedicine, Vol. 189
-
Development of an open source platforms for improving the learning process in pharmacy
EDULEARN20 Proceedings: 12th International Conference on Education and New Learning TechnologiesOnline Conference. 6-7 July, 2020. (IATED Academy), pp. 5422-5427
-
Erratum: Assessment of the inter-batch variability of microstructure parameters in topical semisolids and impact on the demonstration of equivalence (Pharmaceutics, (2019) 11, 10.3390/pharmaceutics11100503)
Pharmaceutics
-
Influence of inter-and intra-batch variability on the sample size required for demonstration of equivalent microstructure of semisolid dosage forms
Pharmaceutics, Vol. 12, Núm. 12, pp. 1-15
-
Physiologically-based pharmacokinetic/ pharmacodynamic model of MBQ-167 to predict tumor growth inhibition in mice
Pharmaceutics, Vol. 12, Núm. 10, pp. 1-17